Workflow
CABIO(688089)
icon
Search documents
嘉必优(688089.SH):首次回购42.81万股公司股份
Ge Long Hui A P P· 2025-09-09 14:00
Group 1 - The company, Jia Bi You (688089.SH), announced its first share buyback on September 9, 2025, through the Shanghai Stock Exchange trading system [1] - A total of 428,100 shares were repurchased, accounting for 0.25% of the company's current total share capital [1] - The highest transaction price was 28.58 yuan per share, while the lowest was 27.25 yuan per share, with a total transaction amount of 11.9991 million yuan (excluding stamp duty and transaction commissions) [1]
嘉必优(688089) - 嘉必优生物技术(武汉)股份有限公司关于第二期以集中竞价交易方式首次回购公司股份的公告
2025-09-09 13:34
2025 年 7 月 10 日,因公司实施 2024 年年度权益分派,第二期回购方案的 回购价格上限由 25.00 元/股(含)调整为 24.80 元/股(含),调整后的回购价格 上限于 2025 年 7 月 10 日生效。具体内容详见公司于 2025 年 7 月 3 日在上海证 券交易所网站(www.sse.com.cn)上披露的《嘉必优生物技术(武汉)股份有限公 司关于 2024 年年度权益分派实施后调整第二期回购股份价格上限的公告》(公告 编号:2025-054)。 证券代码:688089 证券简称:嘉必优 公告编号:2025-072 嘉必优生物技术(武汉)股份有限公司 关于第二期以集中竞价交易方式首次回购公司股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 | 回购方案首次披露日 | 2025 年 1 月 日 | | 25 | | | --- | --- | --- | --- | --- | | 回购方案实施期限 | 董事会审议通过后 12 个月内 | | | | | 预计回购金额 | 1,500 万元 ...
嘉必优:完成首次回购0.25%公司股份
Xin Lang Cai Jing· 2025-09-09 13:29
Core Viewpoint - The company has initiated its first share buyback through the Shanghai Stock Exchange, indicating a strategic move to enhance shareholder value and confidence in its stock performance [1] Summary by Relevant Sections - **Share Buyback Details** - The company repurchased 428,100 shares, which represents 0.25% of its total share capital [1] - The highest transaction price was 28.58 CNY per share, while the lowest was 27.25 CNY per share [1] - The total amount spent on the buyback was 11.9991 million CNY, excluding transaction fees [1] - **Compliance and Regulations** - The share buyback is in accordance with legal regulations and meets the requirements of the company's second phase of the share repurchase plan [1]
嘉必优生物技术(武汉)股份有限公司 关于调整第二期以集中竞价方式回购公司股份价格上限的公告
Core Viewpoint - The company has adjusted the upper limit for the repurchase price of its shares to enhance market value and ensure the smooth implementation of the buyback plan [4][7]. Group 1: Buyback Plan Overview - On January 24, 2025, the company approved a plan to repurchase shares using its own funds and a special loan, with a total repurchase amount between RMB 15 million and RMB 30 million, and an initial price limit of RMB 25.00 per share [2]. - The price limit was adjusted to RMB 24.80 per share starting from July 10, 2025, due to annual equity distribution matters [2]. Group 2: Implementation Status - As of the date of the announcement, the company has not yet implemented the share buyback [3]. Group 3: Price Limit Adjustment Details - The upper limit for the repurchase price has been increased from RMB 24.80 to RMB 35.00 per share, effective from September 9, 2025 [6]. - The adjusted price is set at 150% of the average trading price over the previous 30 trading days [4]. - Based on the total share capital of 168,309,120 shares, the estimated minimum and maximum number of shares to be repurchased are approximately 428,571 shares and 857,142 shares, respectively [4]. Group 4: Impact of Price Adjustment - The adjustment of the repurchase price limit is intended to ensure the successful implementation of the buyback and is not expected to negatively impact the company's operations, finances, research and development, profitability, or future development [7]. Group 5: Decision-Making Process - The adjustment was approved during the ninth meeting of the fourth board of directors and the ninth meeting of the fourth supervisory board held on September 8, 2025, without the need for shareholder approval [8][12].
嘉必优:关于调整第二期以集中竞价方式回购公司股份价格上限的公告
Zheng Quan Ri Bao· 2025-09-08 13:39
Group 1 - The company announced an adjustment to the maximum repurchase price for its second phase of stock buyback from RMB 24.80 per share to RMB 35.00 per share [2] - The adjustment will take effect starting September 9, 2025, and does not require approval from the company's shareholders' meeting [2]
嘉必优:第四届董事会第九次会议决议公告
Zheng Quan Ri Bao· 2025-09-08 12:13
证券日报网讯 9月8日晚间,嘉必优发布公告称,公司第四届董事会第九次会议审议通过了《关于调整 第二期以集中竞价方式回购股票价格上限的议案》。 (文章来源:证券日报) ...
嘉必优:第四届监事会第九次会议决议公告
Zheng Quan Ri Bao· 2025-09-08 12:13
Group 1 - The company announced the approval of a proposal to adjust the upper limit of the stock repurchase price for the second phase of stock buyback through centralized bidding [2] - This decision was made during the ninth meeting of the fourth supervisory board [2] - The announcement was made on the evening of September 8 [2]
嘉必优:9月8日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-08 10:47
Company Overview - Jia Bi You (SH 688089) announced on September 8 that its fourth board meeting will be held in a hybrid format, discussing the adjustment of the maximum repurchase price for its second phase of stock buyback [1] - As of the report, Jia Bi You has a market capitalization of 4.6 billion yuan [1] Revenue Composition - For the year 2024, Jia Bi You's revenue composition is as follows: Human Nutrition accounts for 94.27%, Animal Nutrition for 2.96%, Other Businesses for 2.4%, and Personal Care and Cosmetics for 0.38% [1]
嘉必优(688089) - 嘉必优生物技术(武汉)股份有限公司关于调整第二期以集中竞价方式回购公司股份价格上限的公告
2025-09-08 10:47
证券代码:688089 证券简称:嘉必优 公告编号:2025-069 嘉必优生物技术(武汉)股份有限公司 关于调整第二期以集中竞价方式回购公司股份价格上限的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、回购股份的基本情况 2025 年 7 月 10 日起,因 2024 年年度权益分派事项,公司回购股份的价格 上限由 25.00 元/股(含)调整为 24.80 元/股(含)。具体详见公司于 2025 年 7 月 3 日在上海证券交易所网站(www.sse.com.cn)披露的《嘉必优生物技术(武汉) 股份有限公司关于 2024 年年度权益分派实施后调整第二期回购股份价格上限的 公告》(公告编号:2025-054)。 调整前回购价格上限:不超过人民币 24.80 元/股(含) 调整后回购价格上限:不超过人民币 35.00 元/股(含) 回购价格上限调整起始日:2025 年 9 月 9 日 二、本次回购股份的实施情况 截至本公告日,公司暂未实施回购。 三、本次调整回购股份价格上限的具体情况 基于对公 ...
嘉必优(688089) - 嘉必优生物技术(武汉)股份有限公司第四届监事会第九次会议决议公告
2025-09-08 10:45
一、监事会会议召开情况 嘉必优生物技术(武汉)股份有限公司(以下简称"公司")第四届监事会第 九次会议(以下简称"本次会议")于 2025 年 9 月 8 日以现场结合通讯形式召开。 会议通知已于 2025 年 9 月 5 日通过邮件方式送达全体监事。本次会议应出席监 事 3 人,实际出席监事 3 人,会议由监事会主席王纪召集并主持。本次会议的 召集、召开和表决程序符合有关法律法规、规范性文件和《公司章程》的规定。 二、监事会会议审议情况 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码:688089 证券简称:嘉必优 公告编号:2025-070 嘉必优生物技术(武汉)股份有限公司 第四届监事会第九次会议决议公告 经与会监事审议表决,通过了以下议案: 议案一、审议通过《关于调整第二期以集中竞价方式回购股票价格上限的 议案》 经审议,监事会认为:公司本次调整第二期回购股份价格上限,是基于市 场动态和公司经营情况,维护公司市场价值,传递公司发展信心的合理举措, 不存在损害全体股东特别是中小股东利益的情形,同意本次议案。 ...